The global inflammatory bowel disease drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Inflammatory bowel disease (IBD) is an umbrella term that is used to describe disorders involving chronic inflammation of the digestive tract. The major factor driving the growth of the market is the increasing prevalence of IBD across the globe.
According to Frontiers Org, annual incidences of IBD reached 7.24, 6.82, 10.27, and 13.33 per 100,000, respectively from 2017 to 2020. Additionally, there are two types of IBD including Crohn’s disease (CD) and Ulcerative Colitis (UC). Moreover, annual incidences of CD reached 4.48, 5.26, 7.39, and 9.8 per 100,000, respectively, while that of UC were each 2.76, 1.56, 2.88, and 3.53 per 100,000, respectively. Hence, the increasing prevalence of IBD is driving the demand for inflammatory bowel disease drugs which in turn is driving the growth of the market.
To Request a Sample of our Report on Inflammatory Bowel Disease Drugs Market: https://www.omrglobal.com/request-sample/inflammatory-bowel-disease-drugs-market
Some major players in the market include AbbVie Inc., Amgen Inc., and Bristol-Myers Squibb Co., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2021, Bristol Myers Squibb announced the approval of Zeposia (ozanimod) from the US Food and Drug Administration (FDA). It is used for the treatment of moderate to severely active ulcerative colitis in adults.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Drug Class
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– AbbVie Inc., Amgen Inc., and Bristol-Myers Squibb Co., among others.
(Get 15% Discount on Buying this Report)
A full Report of Inflammatory Bowel Disease Drugs Market is Available @ https://www.omrglobal.com/industry-reports/inflammatory-bowel-disease-drugs-market
Global Inflammatory Bowel Disease Drugs Market Report by Segment
By Type
- Crohn’s Disease
- Ulcerative Colitis
By Drug Class
- Aminosalicylates
- Corticosteroids
- TNF inhibitors
- IL inhibitors
- Anti-integrin
- JAK inhibitors
- Others
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
Global Inflammatory Bowel Disease Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
